PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial.

Hafezi, Farhad; Hosny, Mohammed; Shetty, Rohit; Knyazer, Boris; Chen, Shihao; Wang, Qinmei; Hashemi, Hassan; Torres-Netto, Emilio A

Hafezi, Farhad; Hosny, Mohammed; Shetty, Rohit; Knyazer, Boris; Chen, Shihao; Wang, Qinmei; Hashemi, Hassan; Torres-Netto, Emilio A.

Afiliación

Hafezi F; Center for Applied Biotechnology and Molecular Medicine (CABMM), University of Zurich, Zurich, Switzerland. fhafezi@elza-institute.com.
Hosny M; ELZA Institute, Dietikon, Switzerland. fhafezi@elza-institute.com.
Shetty R; Faculty of Medicine, University of Geneva, Geneva, Switzerland. fhafezi@elza-institute.com.
Knyazer B; Department of Ophthalmology, Medical University of Wenzhou, Wenzhou, China. fhafezi@elza-institute.com.
Chen S; USC Roski Eye Institute, University of Southern California Los Angeles, Los Angeles, USA. fhafezi@elza-institute.com.
Wang Q; Department of Ophthalmology, University of Cairo, Cairo, Egypt.
Hashemi H; Narayana Nethralaya Eye Hospital and the Postgraduate Institute of Ophthalmology, Bangalore, India.
Torres-Netto EA; Department of Ophthalmology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beersheba, Israel.

Eye Vis (Lond) ; 9(1): 2, 2022 Jan 07.

Article en En | MEDLINE | ID: mdl-34996516

Palabras clave

Corneal cross-linking; Corneal melting; Infectious keratitis; PACK-CXL; Photoactivated chromophore

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Eye Vis (Lond) Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google